Galapagos NV announced the appointment of Aaron Cox as Chief Financial Officer, effective July 7, 2025. Aaron Cox, who previously served as Executive Vice President and CFO at Horizon Therapeutics, will succeed Thad Huston. Cox will oversee Finance, Accounting, Tax, Procurement, Communications, and Investor Relations, and will join the Executive Committee. He will also collaborate with leadership and the Board to drive business development and pipeline growth.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.